Barely Significant
← all excerpts

Clinical Characteristics of EGPA Patients in Comparison to GPA Subgroup with Increased Blood Eosinophilia from POLVAS Registry.

J Immunol Res · 2024 · PMC11065486 · PMID 38699219

Europe PMCDOI
1
hedged sentence
0.0400
closest p · 0.8× alpha
0.0400
boldest claim

The sentences

borderline significantp = 0.04actually significant
Treatments used in both subsets were also the same, apart from the borderline significant, more prevalent use of oral glucocorticosteroids for the remission induction phase in GPA NE (54.76% vs. 71.53%, p = 0.04).

also in 11,409 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.